# A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants

> **NCT03494907** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Seltorexant
- **OTHER:** Placebo Matched to Seltorexant
- **OTHER:** Placebo Matched to Moxifloxacin
- **DRUG:** Moxifloxacin Dose 1

## Key facts

- **NCT ID:** NCT03494907
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-09
- **Primary completion:** 2018-08-13
- **Final completion:** 2018-08-13
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03494907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03494907, "A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03494907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*